---
title: "Tellgen: Completed the repurchase of 737,000 shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/260598705.md"
description: "Tellgen announced that the company will repurchase 737,000 shares through centralized bidding from August 28, 2025, to September 30, 2025, accounting for 0.45% of the company's current total share capital. The maximum repurchase price is RMB 29.34 per share, the minimum price is RMB 23.89 per share, and the total amount is RMB 20.0269 million. All repurchased shares will be used for the employee stock ownership plan or equity incentive plan"
datetime: "2025-10-10T10:04:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260598705.md)
  - [en](https://longbridge.com/en/news/260598705.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260598705.md)
generator: "portal-rs"
---

# Tellgen: Completed the repurchase of 737,000 shares

Tellgen announced that the company will repurchase 737,000 shares through centralized bidding from August 28, 2025, to September 30, 2025, accounting for 0.45% of the company's current total share capital. The maximum repurchase price is RMB 29.34 per share, the minimum price is RMB 23.89 per share, with a total amount of RMB 20.0269 million. All repurchased shares will be used for the employee stock ownership plan or equity incentive plan

### Related Stocks

- [300642.CN](https://longbridge.com/en/quote/300642.CN.md)

## Related News & Research

- [13:49 ETVascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease](https://longbridge.com/en/news/296524035.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [17:15 ETHost Defense® Launches New Functional Mushroom Supplement for Pets](https://longbridge.com/en/news/296402242.md)
- [07:55 ETSAPPHIRE LENSES & WINDOWS PROTECT SENSITIVE ELECTRO-OPTICAL SYSTEMS](https://longbridge.com/en/news/296224371.md)
- [04:20 ETSphingoTec to Engage with Clinical and Industry Partners at Major 2026 Conferences](https://longbridge.com/en/news/296322953.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**